Balchem Co. (NASDAQ:BCPC) Shares Purchased by Algert Global LLC

Algert Global LLC boosted its stake in shares of Balchem Co. (NASDAQ:BCPC - Free Report) by 17.1% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 20,813 shares of the basic materials company's stock after buying an additional 3,032 shares during the period. Algert Global LLC owned approximately 0.06% of Balchem worth $3,392,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of BCPC. Barclays PLC increased its stake in Balchem by 405.8% in the third quarter. Barclays PLC now owns 60,777 shares of the basic materials company's stock worth $10,695,000 after purchasing an additional 48,762 shares during the period. Wilmington Savings Fund Society FSB purchased a new position in shares of Balchem in the 3rd quarter valued at $35,000. Tidal Investments LLC lifted its position in shares of Balchem by 10.5% during the third quarter. Tidal Investments LLC now owns 7,975 shares of the basic materials company's stock valued at $1,404,000 after buying an additional 761 shares during the last quarter. Watts Gwilliam & Co. LLC grew its holdings in Balchem by 63.7% in the fourth quarter. Watts Gwilliam & Co. LLC now owns 35,069 shares of the basic materials company's stock worth $5,438,000 after purchasing an additional 13,642 shares during the last quarter. Finally, Argent Capital Management LLC increased its position in shares of Balchem by 39.1% during the fourth quarter. Argent Capital Management LLC now owns 5,821 shares of the basic materials company's stock worth $949,000 after purchasing an additional 1,636 shares in the last quarter. 87.91% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several research analysts recently issued reports on the company. HC Wainwright set a $180.00 target price on Balchem and gave the company a "buy" rating in a research report on Monday, April 28th. Sidoti raised shares of Balchem to a "hold" rating in a research report on Tuesday, February 25th. Finally, StockNews.com lowered shares of Balchem from a "buy" rating to a "hold" rating in a report on Tuesday, February 25th.

Balchem Stock Performance

Shares of NASDAQ:BCPC traded down $1.58 during midday trading on Friday, reaching $163.60. The company's stock had a trading volume of 98,186 shares, compared to its average volume of 134,781. The company has a quick ratio of 1.16, a current ratio of 1.99 and a debt-to-equity ratio of 0.19. The stock has a fifty day moving average of $162.43 and a 200 day moving average of $166.47. Balchem Co. has a twelve month low of $145.70 and a twelve month high of $186.03. The firm has a market capitalization of $5.34 billion, a PE ratio of 41.63, a P/E/G ratio of 4.41 and a beta of 0.93.

Balchem (NASDAQ:BCPC - Get Free Report) last announced its quarterly earnings results on Thursday, April 24th. The basic materials company reported $1.22 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.25 by ($0.03). Balchem had a return on equity of 11.37% and a net margin of 13.47%. The firm had revenue of $250.52 million for the quarter, compared to analysts' expectations of $245.70 million. During the same period last year, the company posted $1.03 earnings per share. The business's quarterly revenue was up 4.5% on a year-over-year basis. On average, equities analysts expect that Balchem Co. will post 4.64 EPS for the current fiscal year.

Balchem Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.